Eli Lilly is on Trump’s list as having committed $27 billion in investments. But that’s on top of an earlier commitment. In ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

Directors of five NIH institutes have been placed on administrative leave or offered new assignments as part of sweeping HHS ...

Viking Therapeutics (NASDAQ: VKTX) is operating in one of the highest-growth pharma areas around. Viking doesn't sell weight ...

Eli Lilly (NYSE: LLY) is the most valuable healthcare company in the world, worth more than $700 billion. Over the past 12 ...

Biopharma leaders react to the forced resignation of CDER Head Peter Marks as RFK Jr.’s promised job cuts begin at the FDA; ...

European healthcare stocks tumble as Trump prepares new tariffs, with pharmaceutical firms bracing for economic fallout and market uncertainty.

Weil Gotshal & Manges partner Amy Rubin is joining Sidley Austin as co-head of its employee benefits and executive ...

Eli Lilly's Alzheimer's treatment is approved for use in the U.S. but the European Medicines Agency recommended against the ...

Altria has an impressive streak of raising its dividend for 55 consecutive years. Eli Lilly's current streak only goes back to 2015. But while Altria has a more impressive track record, that doesn't ...

On Sunday, March 16, 14 members of the Rockbridge County 4-H Stockman’s Club traveled to Blacksburg to compete at Virginia ...

Eli Lilly and Company, Corcept Therapeutics, and AbbVie are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks represent the publicly ...